Bioseet is a digital partnering tool to initiate innovative medicines, biosimilars and generics deals. On the bioseet platform customers can
1. Search for available innovative medicines, biosimilar and generics assets - asset information includes key asset data, the actual project development status and the aspired playing field, i.e. deal structure and partner capabilities
2. Evaluate asset opportunities within teams via asset related votings, recommendations and team-chat-rooms
3. Exchange information with asset vendor via anonymous chat-room and option to mutually disclose identity and contact information.
Bioseet was founded 2019 by Olaf Ucksche.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Kopernikusstraße 11, Munich,81679,germany
- Industry
- Biotechnology
- Website
- bioseet.com
- Keywords
- Generics, Biosimilars, Value Added Medicines, Non-infringing Formulas, Finished Dosage Forms, Out-Licensing, In-Licensing, Business Development.
- HQ
- Munich
Bioseet Questions
Bioseet's website is bioseet.com
Bioseet's LinkedIn profile is https://de.linkedin.com/company/bioseet-gmbh
Bioseet has
3 employees.
View email and phone details for 3
employees at Bioseet.
Bioseet's industry is
Biotechnology
Bioseet's top competitors are
Xcapit,
Energia Vectorial,
Cepe Di Tella,
Hopewell Pharma Ventures,
Findcontrol,
Resobus Consulting,
Aeria Gmbh,
Eijsink,
Alba Capital Partners,
Quinto Impacto.
Bioseet's categories are Biotechnology
Bioseet's founding year is 2019
